 "Wockhardt tanks on US FDA import alert report")
Wockhardt has plunged nearly 14% to Rs 406 on media reports that the U S Food and Drug Administration (US FDA) issued an import alert for the drug maker's Chikalthana facility at Aurangabad.
Meanwhile, on Tuesday, shares of the pharmaceutical company had dipped 4% after the company dropped from the MSCI India index. MSCI is a leading provider of benchmark indices globally.
The stock opened at Rs 462 and touched high of Rs 467 in early morning deals on the Bombay Stock Exchange (BSE). A combined 3.33 million shares have changed hands on the counter till 0945 hours on the BSE and (National Stock Exchange) NSE.
Meanwhile, on Tuesday, shares of the pharmaceutical company had dipped 4% after the company dropped from the MSCI India index. MSCI is a leading provider of benchmark indices globally.
The stock opened at Rs 462 and touched high of Rs 467 in early morning deals on the Bombay Stock Exchange (BSE). A combined 3.33 million shares have changed hands on the counter till 0945 hours on the BSE and (National Stock Exchange) NSE.